MedPath

PURI-PRO - Symptoms Impact and eHealth Intervention for Menopausal Women With Urinary Incontinence

Not Applicable
Recruiting
Conditions
Urinary Incontinence
Registration Number
NCT06527638
Lead Sponsor
ISPA - Instituto Universitario de Ciencias Psicologicas, Sociais e da Vida
Brief Summary

Urinary Incontinence (UI) is a public health problem that disrupts the Quality of Life, Productivity, Social Isolation and Sexual Function; its prevalence in peri- and postmenopausal women is around 30-40%. UI remains underreported and undertreated. Previous eHealth interventions have been efficacious with women.

Thus, PURI-PRO (Portuguese Urinary Incontinence Project) (FCT Grant 2020.05710.BD) entailed a low-cost 8-week eHealth cognitive-behavioural intervention aimed at reducing symptoms through Pelvic Floor Muscle Training, development of healthy bladder habits, and promotion of adherence to exercises, realistic UI-beliefs, and functional coping strategies.

Urinary incontinence symptom severity, frequency and its impact on quality of life, beliefs and strategies regarding urinary incontinence, self-esteem, social isolation, and adherence to pelvic floor muscle excercises were evaluated.

Detailed Description

PURI-PRO's intervention followed an experimental design (randomised controlled trial) involving UI intervention (Experimental Group-EG) vs. Health Literacy single-leaflet (Control Group-CG), both delivered through the internet (eHealth). The study was comparative, since the sample was distributed in two groups (EG vs CG) through randomised distribution, and longitudinal, since all the outcome measures were evaluated at four different times.

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
80
Inclusion Criteria
  • Age (40-65 years);
  • Sex (women);
  • The presence of UI (positive response to a question about experiencing involuntary urine loss during intra-abdominal pressure increment and/or when feeling an incontrollable urge to urinate, occasionally or frequently);
  • Internet access.
Exclusion Criteria
  • Pregnancy or delivery in the past 6 months;
  • Previous UI-related surgery;
  • History of pelvic prolapse:
  • Known malignancy in the lower abdomen;
  • Neurological disease that could affect bladder control;
  • Substance use disorder.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Brief Assessment of Urinary Incontinence symptoms and impact of Quality of LifeChange from Baseline urinary incontinence symptoms and impact on quality of life adherence to mid-intervention (1 month later), post-intervention (2 months later), and at a 3 month follow-up

Evaluated by "International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form" (ICIQ-UI SF)

UI-related Coping StrategiesChange from Baseline UI-related coping strategies to mid-intervention (1 month later), post-intervention (2 months later), and at a 3 month follow-up

Evaluated by a bi-factorial instrument (hiding coping dimension and defensive coping dimension) developed by our team that entails a set of UI-related maladaptive coping strategies to manage immediate effects of UI. This instrument is based on the work of Diokno and collaborators.

UI-related BeliefsChange from Baseline UI-related beliefs to mid-intervention (1 month later), post-intervention (2 months later), and at a 3 month follow-up

Evaluated by the Portuguese version of the "Brief Illness Perception Questionnaire" (IPQ-Brief). This instrument is based on the work of Figueiras and collaborators.

Secondary Outcome Measures
NameTimeMethod
Urinary Incontinence symptom severity and impactChange from Baseline Urinary Incontinence symptom severity and impact to mid-intervention (1 month later), post-intervention (2 months later), and at a 3 month follow-up

Evaluated by "King´s Health Questionnaire" (KHQ)

Self-reported Quality of LifeChange from Baseline quality of life to mid-intervention (1 month later), post-intervention (2 months later), and at a 3 month follow-up

Evaluated by the Portuguese version of the "WHO Quality-of-Life-Bref" (WHOQOL-Bref).

Behavior Change (HAPA)Change from Baseline behavior to mid-intervention (1 month later), post-intervention (2 months later), and at a 3 month follow-up

Evaluated by the HAPA Questionnaire (tailored to Urinary Incontinence symptoms), based on Renner's and Schwarzer's RACK study

Self-esteemChange from Baseline self-esteem to mid-intervention (1 month later), post-intervention (2 months later), and at a 3 month follow-up

Evaluated by the Rosenberg Self-Esteem Scale (RSS)

Social IsolationChange from Baseline social isolation to mid-intervention (1 month later), post-intervention (2 months later), and at a 3 month follow-up

Evaluated by "Social Isolation Questionnaire" (tailored to Urinary Incontinence symptoms) (UI-SIQ). This questionnaire is still on the process of being published by our team.

Pelvic Floor and UI KnowledgeChange from Baseline pelvic floor and UI knowledge to mid-intervention (1 month later), post-intervention (2 months later), and at a 3 month follow-up

Evaluated by "Prolapse and Incontinence Knowledge Questionnaire" (PIKQ-UI)

Pelvic Floor Muscle Exercises AdherenceChange from Baseline pelvic floor muscle exercises adherence to mid-intervention (1 month later), post-intervention (2 months later), and at a 3 month follow-up

Evaluated by a checklist developed by Alewijnse and collaborators that includes items regarding the frequency, ease and satisfaction towards the pelvic floor muscle exercises

Trial Locations

Locations (1)

ISPA-IU

🇵🇹

Lisboa, Portugal

© Copyright 2025. All Rights Reserved by MedPath